Impact and Relevance of Adherence to Interferons in Multiple Sclerosis - National Multiple Sclerosis Society

Skip to navigation Skip to content

Impact and Relevance of Adherence to Interferons in Multiple Sclerosis

Share

Details
August 21, 2013 - August 21, 2014

Recurring Event
CMEs for this program are live until August 21, 2014

In Person

Description

The intended audience for this activity is neurologists, neurology nurses, pharmacists and other healthcare professionals involved in the treatment of patients with multiple sclerosis. At the conclusion of this activity participants should be able to: • Assess patient and medication-related factors which may affect patient adherence and persistence to treatment for multiple sclerosis. • Incorporate management strategies that reduce relapses of relapsing-remitting multiple sclerosis and improve adherence to interferon-beta therapies to minimize negative impacts on patients. • Employ individualized patient management programs, education and support to improve adherence to multiple sclerosis therapy. Faculty: Guy J. Buckle, MD, MPH, Chair; Aaron Boster, MD; Patricia Kennedy, RN, CNP, MSCN; Lynn Stazzone RN, MSN, NP, MSCN This program is acceptable for 1.5 contact hours of ACPE Continuing Education Credit.

Visit the website

Contact information

cme@vindicomeded.com
1-856-994-9400, ext. 504

Share